How many drugs treat Growth retardation?

Drug Landscape tracks 3 marketed treatments for Growth retardation (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/growth-retardation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Growth retardation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Growth retardation (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Growth retardation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Omnitrope	Somatropin	Serono	Recombinant human growth hormone	Dimeric GH receptors on cell membranes of target tissues	1976-01-01
Omnitrope	Omnitrope	Sandoz		Growth hormone receptor
somatropine	somatropine	Sanofi		Growth hormone receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Sandoz · 1 drug in Growth retardation
Sanofi · 1 drug in Growth retardation
Serono · 1 drug in Growth retardation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Growth retardation:

Cite this brief

Drug Landscape (2026). Growth retardation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/growth-retardation. Accessed 2026-06-10.

Growth retardation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing